Speaker illustration

Doctor Mohammad Ali Mandegar

Mo Mandegar is a senior scientist at Tenaya Therapeutics in San Francisco, California. At Tenaya, Mo has led drug discovery efforts using stem cell technology and phenotypic screening powered by artificial intelligence. His research efforts have resulted in the establishment of a pre-clinical program at Tenaya where the lead molecule is under the final stages of drug development.

Phenotypic screening identifies HDAC6 inhibitors as cardioprotective agents in BAG3 cardiac-knockout mouse model of dilated cardiomyopathy

Event: Heart Failure 2021 Online Congress

Topic: Systolic Ventricular Dysfunction

Session: ePoster session

Thumbnail

This platform is supported by

logo Novo Nordisk